Diagnosis and Treatment of Ventilator-Associated Pneumonia: Fiberoptic Bronchoscopy with Bronchoalveolar Lavage Is Essential

ABSTRACT

The management of patients suspected of having ventilator-associated pneumonia (VAP) requires a strategy for diagnosis and treatment that is designated to: (1) identify patients with true lung bacterial infection; (2) determine the pathogen(s) responsible for pneumonia; (3) permit early selection of appropriate antimicrobial therapy; and (4) avoid indiscriminate administration of antibiotics. The use of bronchoscopic techniques to obtain bronchoalveolar lavage (BAL) specimens from the affected area in the lung allows definition of a strategy superior to that based exclusively on clinical evaluation. When BAL is performed before introduction of new antibiotics, it enables physicians to identify patients who need immediate treatment and help to select initial antibiotic therapy (with the results of direct examination of BAL liquid) and to withhold, deescalate, and/or optimize treatment (when the results of quantitative cultures are available), in a manner that is safe and well tolerated by patients. This strategy, based on clinical and bacteriological evaluation, prevents resorting to broad-spectrum drug coverage in all patients who develop signs and symptoms suggestive of pneumonia, thus minimizing the emergence of resistant flora, and redirects the search for another infection site.

KEYWORDS

Ventilator-associated pneumonia - bronchoalveolar lavage (BAL) - quantitative cultures - bronchoscopy - antimicrobial resistance

REFERENCES

• 1 Niederman M S, Torres A, Summer W. Invasive diagnostic testing is not needed routinely to manage suspected ventilator-associated pneumonia.  Am J Respir Crit Care Med. 1994;  150 565-569
• 2 Chastre J, Fagon J Y. Invasive diagnostic testing should be routinely used to manage ventilated patients with suspected pneumonia.  Am J Respir Crit Care Med. 1994;  150 570-574
• 3 Craven D E, Steger K A. Nosocomial pneumonia in mechanically ventilated adult patients: epidemiology and prevention in 1996.  Semin Respir Infect. 1996;  11 32-53
• 4 Johanson W G, Pierce A K, Sanford J P, Thomas G D. Nosocomial respiratory infections with gram-negative bacilli: the significance of colonization of the respiratory tract.  Ann Intern Med. 1972;  77 701-706
• 5 Garrouste-Orgeas M, Chevret S, Arlet G et al.. Oropharyngeal or gastric colonization and nosocomial pneumonia in adult intensive care unit patients: a prospective study based on genomic DNA analysis.  Am J Respir Crit Care Med. 1997;  156 1647-1655
• 6 Chastre J, Fagon J Y. Ventilator-associated pneumonia.  Am J Respir Crit Care Med. 2002;  165 867-903
• 7 Andrews C P, Coalson J J, Smith J D, Johanson W G. Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury.  Chest. 1981;  80 254-258
• 8 Meduri G U, Mauldin G L, Wunderink R G et al.. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia.  Chest. 1994;  106 221-235
• 9 Wunderink R G, Woldenberg L S, Zeiss J, Day C M, Ciemins J, Lacher D A. The radiologic diagnosis of autopsy-proven ventilator-associated pneumonia.  Chest. 1992;  101 458-463
• 10 Baselski V. Microbiologic diagnosis of ventilator-associated pneumonia.  Infect Dis Clin North Am. 1993;  7 331-357
• 11 Kollef M H. Ventilator-associated pneumonia: a multivariate analysis.  JAMA. 1993;  270 1965-1970
• 12 McGowan J E. Antimicrobial resistance in hospital organisms and its relation to antibiotic use.  Rev Infect Dis. 1983;  5 1033-1048
• 13 Kollef M H, Sherman G, Ward S, Fraser V J. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.  Chest. 1999;  115 462-474
• 14 Iregui M, Ward S, Sherman G, Fraser V J, Kollef M H. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia.  Chest. 2002;  122 262-268
• 15 Celis R, Torres A, Gatell J M, Almela M, Rodriguez-Roisin R, Agusti-Vidal A. Nosocomial pneumonia: a multivariate analysis of risk and prognosis.  Chest. 1988;  93 318-324
• 16 Hanberger H, Garcia-Rodriguez J A, Gobernado M, Goossens H, Nilsson L E, Struelens M J. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups.  JAMA. 1999;  281 67-71
• 17 Trouillet J L, Chastre J, Vuagnat A et al.. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.  Am J Respir Crit Care Med. 1998;  157 531-539
• 18 Fagon J Y, Chastre J, Domart Y et al.. Nosocomial pneumonia in patients receiving continuous mechanical ventilation: prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques.  Am Rev Respir Dis. 1989;  139 877-884
• 19 Rello J, Ausina V, Ricart M, Castella J, Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia.  Chest. 1993;  104 1230-1235
• 20 Waterer G W, Wunderink R G. Controversies in the diagnosis of ventilator-associated pneumonia.  Med Clin North Am. 2001;  85 1565-1581
• 21 Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group.  Intensive Care Med. 1996;  22 387-394
• 22 Rello J, Gallego M, Mariscal D, Sonora R, Valles J. The value of routine microbial investigation in ventilator-associated pneumonia.  Am J Respir Crit Care Med. 1997;  156 196-200
• 23 Kirtland S H, Corley D E, Winterbauer R H et al.. The diagnosis of ventilator-associated pneumonia: a comparison of histologic, microbiologic, and clinical criteria.  Chest. 1997;  112 445-457
• 24 Bonten M J, Bergmans D C, Stobberingh E E et al.. Implementation of bronchoscopic techniques in the diagnosis of ventilator-associated pneumonia to reduce antibiotic use.  Am J Respir Crit Care Med. 1997;  156 1820-1824
• 25 Fagon J Y, Chastre J, Wolff M et al.. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial.  Ann Intern Med. 2000;  132 621-630
• 26 Meduri G U, Chastre J. The standardization of bronchoscopic techniques for ventilator-associated pneumonia.  Chest. 1992;  102 557S-564S
• 27 Rouby J J. Histology and microbiology of ventilator-associated pneumonias.  Semin Respir Infect. 1996;  11 54-61
• 28 Meduri G U, Reddy R C, Stanley T, El-Zeky F. Pneumonia in acute respiratory distress syndrome: a prospective evaluation of bilateral bronchoscopic sampling.  Am J Respir Crit Care Med. 1998;  158 870-875
• 29 Baughman R P. Nonbronchoscopic evaluation of ventilator-associated pneumonia.  Semin Respir Infect. 2003;  18 95-102
• 30 Baselski V S, Wunderink R G. Bronchoscopic diagnosis of pneumonia.  Clin Microbiol Rev. 1994;  7 533-558
• 31 Trouillet J L, Guiguet M, Gibert C et al.. Fiberoptic bronchoscopy in ventilated patients: evaluation of cardiopulmonary risk under midazolam sedation.  Chest. 1990;  97 927-933
• 32 Steinberg K P, Mitchell D R, Maunder R J, Milberg J A, Whitcomb M E, Hudson L D. Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome.  Am Rev Respir Dis. 1993;  148 556-561
• 33 Pugin J, Suter P M. Diagnostic bronchoalveolar lavage in patients with pneumonia produces sepsis-like systemic effects.  Intensive Care Med. 1992;  18 6-10
• 34 Moser K M, Maurer J, Jassy L et al.. Sensitivity, specificity, and risk of diagnostic procedures in a canine model of Streptococcus pneumoniae pneumonia.  Am Rev Respir Dis. 1982;  125 436-442
• 35 de Lassence A, Joly-Guillou M L, Martin-Lefevre L et al.. Accuracy of delayed cultures of plugged telescoping catheter samples for diagnosing bacterial pneumonia.  Crit Care Med. 2001;  29 1311-1317
• 36 Bartlett J G, Finegold S M. Bacteriology of expectorated sputum with quantitative culture and wash technique compared to transtracheal aspirates.  Am Rev Respir Dis. 1978;  117 1019-1027
• 37 Kahn F W, Jones J M. Diagnosing bacterial respiratory infection by bronchoalveolar lavage.  J Infect Dis. 1987;  155 862-869
• 38 Chastre J, Fagon J Y, Bornet-Lecso M et al.. Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia.  Am J Respir Crit Care Med. 1995;  152 231-240
• 39 Croce M A, Fabian T C, Waddle-Smith L et al.. Utility of Gram's stain and efficacy of quantitative cultures for posttraumatic pneumonia: a prospective study.  Ann Surg. 1998;  227 743-751
• 40 Chastre J, Fagon J Y, Soler P et al.. Diagnosis of nosocomial bacterial pneumonia in intubated patients undergoing ventilation: comparison of the usefulness of bronchoalveolar lavage and the protected specimen brush.  Am J Med. 1988;  85 499-506
• 41 Allaouchiche B, Jaumain H, Chassard D, Bouletreau P. Gram stain of bronchoalveolar lavage fluid in the early diagnosis of ventilator-associated pneumonia.  Br J Anaesth. 1999;  83 845-849
• 42 Dupont H, Chalhoub V, Plantefève G et al.. Variation of infected cell count in bronchoalveolar lavage and timing of ventilator-associated pneumonia.  Intensive Care Med. 2004;  30 1557-1563
• 43 Torres A, El-Ebiary M, Fabregas N et al.. Value of intracellular bacteria detection in the diagnosis of ventilator associated pneumonia.  Thorax. 1996;  51 378-384
• 44 Veber B, Souweine B, Gachot B et al.. Comparison of direct examination of three types of bronchoscopy specimens used to diagnose nosocomial pneumonia.  Crit Care Med. 2000;  28 962-968
• 45 Timsit J F, Cheval C, Gachot B et al.. Usefulness of a strategy based on bronchoscopy with direct examination of bronchoalveolar lavage fluid in the initial antibiotic therapy of suspected ventilator-associated pneumonia.  Intensive Care Med. 2001;  27 640-647
• 46 Johanson Jr W G, Seidenfeld J J, Gomez P, de los Santos R, Coalson J J. Bacteriologic diagnosis of nosocomial pneumonia following prolonged mechanical ventilation.  Am Rev Respir Dis. 1988;  137 259-264
• 47 Higuchi J H, Coalson J J, Johanson W G. Bacteriologic diagnosis of nosocomial pneumonia in primates: usefulness of the protected specimen brush.  Am Rev Respir Dis. 1982;  125 53-57
• 48 Chastre J, Viau F, Brun P et al.. Prospective evaluation of the protected specimen brush for the diagnosis of pulmonary infections in ventilated patients.  Am Rev Respir Dis. 1984;  130 924-929
• 49 Rouby J J, Martin De Lassale E, Poete P et al.. Nosocomial bronchopneumonia in the critically ill: histologic and bacteriologic aspects.  Am Rev Respir Dis. 1992;  146 1059-1066
• 50 Marquette C H, Copin M C, Wallet F et al.. Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard.  Am J Respir Crit Care Med. 1995;  151 1878-1888
• 51 Torres A, Fabregas N, Ewig S, de la Bellacasa J P, Bauer T T, Ramirez J. Sampling methods for ventilator-associated pneumonia: validation using different histologic and microbiological references.  Crit Care Med. 2000;  28 2799-2804
• 52 de Jaeger A, Litalien C, Lacroix J, Guertin M C, Infante-Rivard C. Protected specimen brush or bronchoalveolar lavage to diagnose bacterial nosocomial pneumonia in ventilated adults: a meta-analysis.  Crit Care Med. 1999;  27 2548-2560
• 53 Baughman R P. Protected-specimen brush technique in the diagnosis of ventilator-associated pneumonia.  Chest. 2000;  117 203S-206S
• 54 Prats E, Dorca J, Pujol M et al.. Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia.  Eur Respir J. 2002;  19 944-951
• 55 Montravers P, Fagon J Y, Chastre J et al.. Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia.  Am Rev Respir Dis. 1993;  147 38-44
• 56 Souweine B, Veber B, Bedos J P et al.. Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: impact of previous antimicrobial treatments.  Crit Care Med. 1998;  26 236-244
• 57 Marquette C H, Wallet F, Copin M C et al.. Relationship between microbiologic and histologic features in bacterial pneumonia.  Am J Respir Crit Care Med. 1996;  154 1784-1787
• 58 Dreyfuss D, Mier L, Le Bourdelles G et al.. Clinical significance of borderline quantitative protected brush specimen culture results.  Am Rev Respir Dis. 1993;  147 946-951
• 59 Heyland D K, Cook D J, Marshall J et al.. The clinical utility of invasive diagnostic techniques in the setting of ventilator-associated pneumonia. Canadian Critical Care Trials Group.  Chest. 1999;  115 1076-1084
• 60 Rello J, Gallego M, Mariscal D, Sonora R, Valles J. The value of routine microbial investigation in ventilator-associated pneumonia.  Am J Respir Crit Care Med. 1997;  156 196-200
• 61 McGowan J E. Antimicrobial resistance in hospital organisms and its relation to antibiotic use.  Rev Infect Dis. 1983;  5 1033-1048
• 62 Kollef M H, Fraser V J. Antibiotic resistance in the intensive care unit.  Ann Intern Med. 2001;  134 298-314
• 63 Croce M A, Fabian T C, Shaw B et al.. Analysis of charges associated with diagnosis of nosocomial pneumonia: can routine bronchoscopy be justified?.  J Trauma. 1994;  37 721-727
• 64 Baker A M, Bowton D L, Haponik E F. Decision making in nosocomial pneumonia: an analytic approach to the interpretation of quantitative bronchoscopic cultures.  Chest. 1995;  107 85-95
• 65 Sterling T R, Ho E J, Brehm W T, Kirkpatrick M B. Diagnosis and treatment of ventilator-associated pneumonia-impact on survival: a decision analysis.  Chest. 1996;  110 1025-1034
• 66 Ost D E, Hall C S, Joseph G et al.. Decision analysis of antibiotic and diagnostic strategies in ventilator associated pneumonia.  Am J Respir Crit Care Med. 2003;  168 1060-1067
• 67 Sanchez-Nieto J M, Torres A, Garcia-Cordoba F et al.. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study.  Am J Respir Crit Care Med. 1998;  157 371-376
• 68 Ruiz M, Torres A, Ewig S et al.. Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome.  Am J Respir Crit Care Med. 2000;  162 119-125
• 69 Sole Violan J, Fernandez J A, Benitez A B, Cardenosa Cendrero J A, Rodriguez de Castro F. Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia.  Crit Care Med. 2000;  28 2737-2741
• 70 Shorr A F, Sherner J H, Jackson W L, Kollef M H. Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis.  Crit Care Med. 2005;  33 46-53
• 71 American Thoracic Society, Infectious Disease Society of America . Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.  Am J Respir Crit Care Med. 2005;  171 388-416